Table 2 Results of interrupted time series showing changes in trend and level change after the information disclosure on diseases
Constant β0 (SE) | Quarterly trend before information disclosure β1 (SE) | Step change when information disclosed β2 (SE) | Change in trend after information disclosure β3 (SE) | |
|---|---|---|---|---|
Thyroid malignant tumors | ||||
Discharge costs per case [RMB] | 14177.888*** | 72.719 | -284.489 | 111.359* |
(198.326) | (44.240) | (280.417) | (45.479) | |
Drug costs per case [RMB] | 3078.871*** | -6.298 | -77.198 | -21.611* |
(35.062) | (9.509) | (99.450) | (10.451) | |
Consumable costs per case [RMB] | 1466.304*** | -11.237 | 199.174** | 89.174*** |
(30.700) | (6.710) | (62.717) | (7.508) | |
Length of stay [days] | 7.370*** | -0.120*** | -0.815*** | 0.080** |
(0.129) | (0.028) | (0.120) | (0.028) | |
Colorectal malignant tumors | ||||
Discharge costs per case [RMB] | 42256.420*** | 1018.438*** | -2837.556 | -574.004* |
(1028.788) | (222.443) | (1446.846) | (240.608) | |
Drug costs per case [RMB] | 14288.657*** | 384.040*** | -1732.9479* | -598.438*** |
(394.854) | (84.565) | (701.918) | (99.221) | |
Consumable costs per case [RMB] | 14673.734*** | 5.130 | -396.835 | 222.859*** |
(14.654) | (3.705) | (291.280) | (21.144) | |
Length of stay [days] | 19.755*** | -0.275*** | -1.423*** | 0.127 |
(0.343) | (0.075) | (0.366) | (0.080) | |